Lidocaine/Morphine

利多卡因/吗啡

Report date: 2026/02/13 10:40:23

Base Information

Drug NameLidocaine/Morphine
Drug Alias Name利多卡因吗啡Morphine/Lidocaine吗啡利多卡因Morphine and LidocaineLidocaine and Morphine +[6] 
ClassificationSmall molecules
Mechanisms of ActionOpioid receptors agonistsSodium channel alpha subunit blockers
TargetsOpioid receptorsSodium channel alpha subunit
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Morphine sulfateLidocaine
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEpiceptMemorial Sloan Kettering Cancer Center
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A